How to cite item

Perioperative chemotherapy and hepatic resection for resectable colorectal liver metastases

   
@article{HBSN4319,
	author = {Toru Beppu and Yasuo Sakamoto and Hiromitsu Hayashi and Hideo Baba},
	title = {Perioperative chemotherapy and hepatic resection for resectable colorectal liver metastases},
	journal = {Hepatobiliary Surgery and Nutrition},
	volume = {4},
	number = {1},
	year = {2014},
	keywords = {},
	abstract = {The role of perioperative chemotherapy in the management of initially resectable colorectal liver metastases (CRLM) is still unclear. The EPOC trial [the European Organization for Research and Treatment of Cancer (EORTC) 40983] is an important study that declares perioperative chemotherapy as the standard of care for patients with resectable CRLM, and the strategy is widely accepted in western countries. Compared with surgery alone, perioperative FOLFOX therapy significantly increased progression-free survival (PFS) in eligible patients or those with resected CRLM. Overall survival (OS) data from the EPOC trial were recently published in The Lancet Oncology, 2013. Here, we discussed the findings and recommendations from the EORTC 40983 trial.},
	issn = {2304-389X},	url = {https://hbsn.amegroups.org/article/view/4319}
}